Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease-Reference-Cited by-同舟云学术

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease

Published:2017-07 Issue: Volume:55 Page:78-90
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Mak Elijah^ORCID,Su Li,Williams Guy B.,Firbank Michael J.,Lawson Rachael A.,Yarnall Alison J.,Duncan Gordon W.,Mollenhauer Brit,Owen Adrian M.,Khoo Tien K.,Brooks David J.,Rowe James B.,Barker Roger A.,Burn David J.,O'Brien John T.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference97 articles.

1. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study;Aarsland;Arch. Neurol.,2003

2. The rate of cognitive decline in Parkinson disease;Aarsland;Arch. Neurol.,2004

3. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis;Anderson;J. Magn. Reson. Imaging,2006

4. Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment;Apostolova;NBA,2012

5. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia;Apostolova;Mov. Disord.,2010

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors;Diagnostics;2024-08-28

2. Automatization and validation of the hippocampal-to-ventricle ratio in a clinical sample;2024-04-15

3. Mild cognitive impairment in Parkinson's disease: current view;Frontiers in Cognition;2024-04-05

4. Structural neuroimaging markers of normal pressure hydrocephalus versus Alzheimer’s dementia and Parkinson’s disease, and hydrocephalus versus atrophy in chronic TBI—a narrative review;Frontiers in Neurology;2024-03-21

5. Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial;NeuroImage: Clinical;2024